331 related articles for article (PubMed ID: 22406538)
21. Cytokine signatures of transformed B cells with distinct Epstein-Barr virus latencies as a potential diagnostic tool for B cell lymphoma.
Miyauchi K; Urano E; Yoshiyama H; Komano J
Cancer Sci; 2011 Jun; 102(6):1236-41. PubMed ID: 21392167
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man.
Rowe M; Young LS; Crocker J; Stokes H; Henderson S; Rickinson AB
J Exp Med; 1991 Jan; 173(1):147-58. PubMed ID: 1845872
[TBL] [Abstract][Full Text] [Related]
23. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders.
Knowles DM; Cesarman E; Chadburn A; Frizzera G; Chen J; Rose EA; Michler RE
Blood; 1995 Jan; 85(2):552-65. PubMed ID: 7812011
[TBL] [Abstract][Full Text] [Related]
24. Interactions involving cyclosporine A, interleukin-6, and Epstein-Barr virus lead to the promotion of B-cell lymphoproliferative disease.
Tanner JE; Alfieri C
Leuk Lymphoma; 1996 May; 21(5-6):379-90. PubMed ID: 9172802
[TBL] [Abstract][Full Text] [Related]
25. EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease.
McKnight JL; Cen H; Riddler SA; Breinig MC; Williams PA; Ho M; Joseph PS
Leuk Lymphoma; 1994 Sep; 15(1-2):9-16. PubMed ID: 7858507
[TBL] [Abstract][Full Text] [Related]
26. An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs.
Gottschalk S; Ng CY; Perez M; Smith CA; Sample C; Brenner MK; Heslop HE; Rooney CM
Blood; 2001 Feb; 97(4):835-43. PubMed ID: 11159505
[TBL] [Abstract][Full Text] [Related]
27. Sequences of cytotoxic T-lymphocyte epitopes in the Epstein-Barr virus (EBV) nuclear antigen-3B gene in a Japanese population with or without EBV-positive lymphoid malignancies.
Kanno H; Nakatsuka S; Iuchi K; Aozasa K
Int J Cancer; 2000 Nov; 88(4):626-32. PubMed ID: 11058881
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus (EBV)-associated lymphoproliferations in severe combined immunodeficient mice transplanted with Hodgkin's disease lymph nodes: implications of EBV-positive bystander B lymphocytes rather than EBV-infected Reed-Sternberg cells.
Meggetto F; Muller C; Henry S; Selves J; Mariamé B; Brousset P; Saati TA; Delsol G
Blood; 1996 Mar; 87(6):2435-42. PubMed ID: 8630408
[TBL] [Abstract][Full Text] [Related]
29. CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease.
Robertson KD; Manns A; Swinnen LJ; Zong JC; Gulley ML; Ambinder RF
Blood; 1996 Oct; 88(8):3129-36. PubMed ID: 8874213
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
Leong IT; Fernandes BJ; Mock D
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.
Watanabe A; Maruo S; Ito T; Ito M; Katsumura KR; Takada K
J Virol; 2010 Mar; 84(6):2893-901. PubMed ID: 20042495
[TBL] [Abstract][Full Text] [Related]
32. The EBNA3 Family: Two Oncoproteins and a Tumour Suppressor that Are Central to the Biology of EBV in B Cells.
Allday MJ; Bazot Q; White RE
Curr Top Microbiol Immunol; 2015; 391():61-117. PubMed ID: 26428372
[TBL] [Abstract][Full Text] [Related]
33. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
Dolcetti R
Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
[TBL] [Abstract][Full Text] [Related]
34. Identification of IgH gene rearrangement and immunophenotype in an animal model of Epstein-Barr virus-associated lymphomas.
Zhang Y; Peng X; Tang Y; Gan X; Wang C; Xie L; Xie X; Gan R; Wu Y
J Med Virol; 2016 Oct; 88(10):1804-13. PubMed ID: 26991077
[TBL] [Abstract][Full Text] [Related]
35. An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link.
Kelly GL; Long HM; Stylianou J; Thomas WA; Leese A; Bell AI; Bornkamm GW; Mautner J; Rickinson AB; Rowe M
PLoS Pathog; 2009 Mar; 5(3):e1000341. PubMed ID: 19283066
[TBL] [Abstract][Full Text] [Related]
36. Human solid tumor xenografts in immunodeficient mice are vulnerable to lymphomagenesis associated with Epstein-Barr virus.
Chen K; Ahmed S; Adeyi O; Dick JE; Ghanekar A
PLoS One; 2012; 7(6):e39294. PubMed ID: 22723990
[TBL] [Abstract][Full Text] [Related]
37. Epstein-Barr Virus (EBV)-Related Lymphoproliferative Disorders in Ataxia Telangiectasia: Does ATM Regulate EBV Life Cycle?
Tatfi M; Hermine O; Suarez F
Front Immunol; 2018; 9():3060. PubMed ID: 30662441
[TBL] [Abstract][Full Text] [Related]
38. Epstein-Barr virus nuclear protein 2 is a critical determinant for tumor growth in SCID mice and for transformation in vitro.
Cohen JI; Picchio GR; Mosier DE
J Virol; 1992 Dec; 66(12):7555-9. PubMed ID: 1331538
[TBL] [Abstract][Full Text] [Related]
39. Proteomics and Transcriptomics of BJAB Cells Expressing the Epstein-Barr Virus Noncoding RNAs EBER1 and EBER2.
Pimienta G; Fok V; Haslip M; Nagy M; Takyar S; Steitz JA
PLoS One; 2015; 10(6):e0124638. PubMed ID: 26121143
[TBL] [Abstract][Full Text] [Related]
40. LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis.
Ma SD; Xu X; Plowshay J; Ranheim EA; Burlingham WJ; Jensen JL; Asimakopoulos F; Tang W; Gulley ML; Cesarman E; Gumperz JE; Kenney SC
J Clin Invest; 2015 Jan; 125(1):304-15. PubMed ID: 25485679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
